Free provider profile

MARK TUNGESVIK, MD

NPI 1497723472
Individual
Internal Medicine, Hematology & Oncology
Active registration
Save to rep workspaceFollow this provider Sign in to find emailNPI registry

Need more providers like MARK TUNGESVIK?

See the count and top 3 free, ranked by Medicare billing. Full list $29, included with membership.

Rep intel

What MARK TUNGESVIK prescribes and who else does

Top Medicare Part D drugs by claims (public CMS data):

  • Revlimid
  • Pomalyst
  • Jakafi
  • Ibrance
  • Brukinsa

See all hematologist-oncologists in MO who bill Medicare →

Your next referral list starts here

Provider + market indicator

A combined screening indicator—not a provider fraud-risk score. Local plan ratings describe the surrounding market, not this provider’s quality, plan membership or wrongdoing.

Comparing current CMS billing with peers and checking OIG and plan ratings… A new peer comparison can take about a minute.

Practice contact card

Practice phone

573-874-7800

Fax

573-443-3627

Practice address

1705 E BROADWAY SUITE 100, COLUMBIA, MO, 65201

Registry updated
2026-07-28
NPI issued
2006-03-08
RepVector retrieved
11/20/2026

A recent retrieval can still contain an old address if the provider has not updated their registry record. Website email checks show their own date under Find email.

Registry record

Source: CMS NPPES registry.

1705 E BROADWAY SUITE 100, COLUMBIA, MO, 65201

573-874-7800

Single practice location

Enumerated 2006-03-08

  • — Registration is active in NPPES.
  • — Individual clinician record — reachable, but usually not the buyer.
  • — Practice phone number is published.
  • — Full street address on file for route planning.
  • — Record updated within the last year.

Medicare Part D prescribing

Source: CMS Medicare Part D Prescribers by Provider, most recent public year.

Part D claims

1,919

Medicare patients

333

Part D drug cost

$5,214,765

Brand-name share

Not published

of this prescriber's Part D claims

DrugClaimsMedicare cost
Revlimid (Lenalidomide)65$1,130,287
Pomalyst (Pomalidomide)33$763,258
Fotivda (Tivozanib Hcl)15$455,200
Jakafi (Ruxolitinib Phosphate)26$313,918
Imbruvica (Ibrutinib)19$298,595
Ibrance (Palbociclib)22$279,008
Brukinsa (Zanubrutinib)20$230,760
Inlyta (Axitinib)11$211,613

Want their full drug mix and peer benchmark? Run the free Part D prescriber lookup.

Latest Medicare Part B billing

CMS Physician and Other Practitioners, by Provider and Service. New published billing years are detected daily, using the same release as the Billing analyst and risk maps.

Loading the latest published CMS billing file…

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

Checking Open Payments…

Industry payments across MO — which companies pay providers there.

Tailored to Provider research.

Build the provider research list for one county and check the names yourself.

Name the city, county, or state. RepVector selects the datasets that matter for provider research, enriches each target with what its site publishes, and returns a scored list with phones, addresses and named contacts.

Build a provider research list

3 free runs — no card required.